An epigenetic role of mitochondria in cancer
Mitochondria are not only the main energy supplier but are also the cell metabolic center
regulating multiple key metaborates that play pivotal roles in epigenetics regulation. These …
regulating multiple key metaborates that play pivotal roles in epigenetics regulation. These …
Histone deacetylase inhibitors as anticancer drugs
T Eckschlager, J Plch, M Stiborova… - International journal of …, 2017 - mdpi.com
Carcinogenesis cannot be explained only by genetic alterations, but also involves
epigenetic processes. Modification of histones by acetylation plays a key role in epigenetic …
epigenetic processes. Modification of histones by acetylation plays a key role in epigenetic …
Recent developments in epigenetic cancer therapeutics: clinical advancement and emerging trends
K Nepali, JP Liou - Journal of Biomedical Science, 2021 - Springer
Epigenetic drug discovery field has evidenced significant advancement in the recent times.
A plethora of small molecule inhibitors have progressed to clinical stage investigations and …
A plethora of small molecule inhibitors have progressed to clinical stage investigations and …
Microbiota-derived metabolite promotes HDAC3 activity in the gut
The coevolution of mammalian hosts and their beneficial commensal microbes has led to
development of symbiotic host–microbiota relationships. Epigenetic machinery permits …
development of symbiotic host–microbiota relationships. Epigenetic machinery permits …
Histone deacetylase inhibitors in clinical studies as templates for new anticancer agents
M Mottamal, S Zheng, TL Huang, G Wang - Molecules, 2015 - mdpi.com
Histone dacetylases (HDACs) are a group of enzymes that remove acetyl groups from
histones and regulate expression of tumor suppressor genes. They are implicated in many …
histones and regulate expression of tumor suppressor genes. They are implicated in many …
New and emerging HDAC inhibitors for cancer treatment
AC West, RW Johnstone - The Journal of clinical …, 2014 - Am Soc Clin Investig
Epigenetic enzymes are often dysregulated in human tumors through mutation, altered
expression, or inappropriate recruitment to certain loci. The identification of these enzymes …
expression, or inappropriate recruitment to certain loci. The identification of these enzymes …
Cancer as a dysregulated epigenome allowing cellular growth advantage at the expense of the host
W Timp, AP Feinberg - Nature Reviews Cancer, 2013 - nature.com
Although at the genetic level cancer is caused by diverse mutations, epigenetic
modifications are characteristic of all cancers, from apparently normal precursor tissue to …
modifications are characteristic of all cancers, from apparently normal precursor tissue to …
[HTML][HTML] Histone deacetylase inhibitors: molecular mechanisms of action and clinical trials as anti-cancer drugs
HJ Kim, SC Bae - American journal of translational research, 2011 - ncbi.nlm.nih.gov
Histone deacetylase (HDAC) inhibitors are a relatively new class of anti-cancer agents that
play important roles in epigenetic or non-epigenetic regulation, inducing death, apoptosis …
play important roles in epigenetic or non-epigenetic regulation, inducing death, apoptosis …
[PDF][PDF] HDAC and HDAC inhibitor: from cancer to cardiovascular diseases
S Yoon, GH Eom - Chonnam medical journal, 2016 - synapse.koreamed.org
Histone deacetylases (HDACs) are epigenetic regulators that regulate the histone tail,
chromatin conformation, protein-DNA interaction, and even transcription. HDACs are also …
chromatin conformation, protein-DNA interaction, and even transcription. HDACs are also …
Anticancer activities of histone deacetylase inhibitors
JE Bolden, MJ Peart, RW Johnstone - Nature reviews Drug discovery, 2006 - nature.com
Histone deacetylases (HDACs) are enzymes involved in the remodelling of chromatin, and
have a key role in the epigenetic regulation of gene expression. In addition, the activity of …
have a key role in the epigenetic regulation of gene expression. In addition, the activity of …